Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CPA3 | P15088 | 3/20 | 0.68 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.64 |
| ▸ | CPA1 | P15085 | 7/20 | 0.61 |
| ▸ | CPB1 | P15086 | 1/20 | 0.61 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.61 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.61 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | XIAP | P98170 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.54 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.53 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL429946 | 0.89 | FOLH1 (0.70) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL6724759 | 0.88 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL12494233 | 0.88 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL19821208 | 0.88 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL6459282 | 0.87 | CYP1A2 (0.54) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| Hydrochloric Acid SCHEMBL30239113 | 0.87 | FOLH1 (0.68) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL3044591 | 0.87 | CYP1A2 (0.57) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL4016996 | 0.86 | FOLH1 (0.66) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL4023050 | 0.86 | FOLH1 (0.66) | CYP1A2CPA3FOLH1CPA1CPB1 | |
| SCHEMBL4017000 | 0.86 | FOLH1 (0.66) | CYP1A2CPA3FOLH1CPA1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2563847-B1 | MCR DENDRIMERS | LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) | 2016-04-13 | — | — | EP | disclosed |
| EP-2563847-A1 | MCR DENDRIMERS | Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134607-A1 | MCR DENDRIMERS | LEIBNIZ-INSTITUT FÜR PFLANZENBIOCHEMIE (DE) | 2011-11-03 | — | — | WO | disclosed |
| US-20080167310-A1 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) | GOSSETT LYNN STACY | 2008-07-10 | — | — | US | disclosed |
| US-7282501-B2 | Modulators of peroxisome proliferator activated receptors (PPAR) | ELI LILLY AND COMPANY (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070207992-A1 | Geldanamycin derivatives and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2007-09-06 | — | — | US | disclosed |
| WO-2007098229-A2 | GELDANAMYCIN DERIVATIVES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2007-08-30 | — | — | WO | disclosed |
| CN-1320359-C | Immunoassay process to detect chemical matter | BOIKEDE INC (US) | 2007-06-06 | — | — | CN | disclosed |
| EP-1401434-B1 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) | LILLY CO ELI (US) | 2006-11-15 | — | — | EP | disclosed |
| US-20050075378-A1 | Modulators of peroxisome proliferator activated receptors (ppar) | ELI LILLY AND COMPANY | 2005-04-07 | — | — | US | disclosed |
| EP-1401434-A1 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) | ELI LILLY AND COMPANY (US) | 2004-03-31 | — | — | EP | disclosed |
| WO-2002100403-A1 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) | ELI LILLY AND COMPANY (US) | 2002-12-19 | — | — | WO | disclosed |
| CN-1071454-C | Method for marking a product and authenticating the product by detecting a marker in the product | BOICKED CO LTD (US) | 2001-09-19 | — | — | CN | disclosed |
| CN-1308236-A | Immunoassay process to detect chemical matter | BOIKEDE INC (US) | 2001-08-15 | — | — | CN | disclosed |
| CN-1037969-A | Detection of chemical substances by immunoassay | SHELL INT RESEARCH (NL) | 1989-12-13 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075378-A1 | Modulators of peroxisome proliferator activated receptors (ppar) | PPARG, PPARA, PPARD | CYP1A2 567/4885CPA3 4707/4885FOLH1 2309/4885 |
| US-20080167310-A1 | MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) | PPARG, PPARA, PPARD | CYP1A2 567/4885CPA3 4707/4885FOLH1 2309/4885 |
| US-20070207992-A1 | Geldanamycin derivatives and method of use thereof | HSP90AB2P, HSP90AB1, HSP90B1 | CYP1A2 2021/4885CPA3 3957/4885FOLH1 1350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.